Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors

Hagan, Holly; McGough, James P.; Thiede, Hanne; Hopkins, Sharon G.; Duchin, Jeffrey S.; Alexander, E. Russell

doi:10.1016/s0740-5472(00)00104-5

Cited by 171 publications

(111 citation statements)

References 13 publications

Supporting

Mentioning

103

Contrasting

Unclassified

Order By: Relevance

“…These findings extend the large body of literature showing the effectiveness of substance abuse treatment in more clinically diverse samples of drug users to syringe exchangers homogeneous for a high baseline severity of drug use (Gowing et al, 2007). At the very least, the present study provides additional empirical support for efforts to increase the rate of substance abuse treatment participation in syringe exchangers (e.g., Des Jarlais et al, 2010;Hagan et al, 2000;Heimer, 1998;Kidorf et al, 2005;Strathdee et al, 2006). While the collateral benefits of reduced illegal activity and incarceration and a strong trend toward fewer emergency room visits are not surprising, they help validate the self-reported decrease in drug use reported by subjects (McLellan, Lewis, O'Brien, & Kleber, 2000).…”

Section: Reduction Of Drug Usesupporting

confidence: 78%

“…Other studies have shown some reduction in drug use for syringe exchangers independent of treatment participation (e.g., Hagan et al, 2000;Watters, Estilo, Clark, & Lorvick, 1994), though the only randomized trial evaluating this question showed no differences in drug use between subjects acquiring syringes from SEP vs. pharmacy settings (Fisher et al, 2003). Taken together, these findings provide additional support that SEP participation does not facilitate higher rates of drug use, and may even be associated with reductions in drug use for some participants.…”

Section: Reduction Of Drug Usementioning

confidence: 59%

See 1 more Smart Citation

Benefits of concurrent syringe exchange and substance abuse treatment participation

Kidorf¹,

King²,

Pierce³

et al. 2011

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Participation in syringe exchange programs (SEPs) is associated with many individual and public health benefits, but may have little impact on reducing drug use without concurrent treatment engagement. The present study evaluated rates of drug use, other risk behaviors, and illegal activities in newly registered SEP participants (n = 240) enrolled versus not enrolled in substance abuse treatment over a 4-month observation window, and examined the effect of days in treatment on these outcomes. After controlling for baseline differences, SEP registrants enrolled in treatment (n = 113) reported less days of opioid and cocaine use, injection drug use, illegal activities, and incarceration than those not enrolled in treatment (n=127). For those enrolled in treatment, days of treatment was strongly correlated with each of these outcomes. These findings provide good evidence for a dose-response effect of treatment in syringe exchangers, and suggest that substance abuse treatment significantly expands the harm reduction benefits of SEP participation.Keywords syringe exchange; substance abuse treatment; injection drug use; HIV risk behaviors; harm reduction I.0 IntroductionCommunity syringe exchange programs (SEPs) are consistently associated with reduced rates of injection equipment sharing and reduced rates of HIV infection (e.g., Bluthenthal, Kral, Gee, Erringer, & Edlin, 2000;Des Jarlais et al., 1996;Des Jarlais, McKnight, Goldblatt, & Purchase, 2009;Gibson et al., 2002;Huo & Ouellet, 2007; see Wodak & Cooney, 2006 for a review). The fact that syringe exchange participation does not fully suppress the sharing of injection equipment is most likely related to the high rates of continuing drug injection in this subgroup of substance users (e.g., Des Jarlais, Braine, Yi, & Turner, 2007;Fisher, Fenaughty, Cagle, & Wells, 2003;Wood et al., 2002). Interventions that fully suppress drug injection would clearly enhance the harm reduction benefits of syringe exchanges. A recent study by Van Den Berg, Smit, Van Brussel, Coutinho, & Prins (2007) reached this conclusion in a study of 714 injection drug users in Amsterdam. Subjects in that study that concurrently participated in syringe exchange and substance Phone for First Author: Phone: (410) 550-0006, Fax: (410) 550-2957, mkidorf@jhmi.edu Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. While several studies have reported on promising strategies to bridge syringe exchange and substance abuse treatment participation (Kidorf et al., 2009;Kuo et al., 2003;Strathdee et al., 2006), little is known about the responsiveness of syringe...

show abstract

Section: Reduction Of Drug Usesupporting

confidence: 78%

Section: Reduction Of Drug Usementioning

confidence: 59%

Benefits of concurrent syringe exchange and substance abuse treatment participation

Kidorf¹,

King²,

Pierce³

et al. 2011

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

show abstract

“…That this intervention can be delivered in one session makes it optimal for use at SEPs, where participants often attend inconsistently. 10,22 Booth and colleagues 23 used a 2 × 2 design to examine the effects of a series of MI sessions and free treatment (for 90 days) on the treatment enrollment of opioid and cocaine users recruited from street settings. All participants who expressed interest in treatment were scheduled an intake and transported to a clinic that provided treatment on demand.…”

Section: Introductionmentioning

confidence: 99%

Challenges in Motivating Treatment Enrollment in Community Syringe Exchange Participants

Kidorf

2005

Journal of Urban Health: Bulletin of the New York Academy of Me

View full text Add to dashboard Cite

show abstract

“…This information is important. For the individual client, long-term retention in the NSEP may moderate the frequency of injection 15 and may reduce the acquisition or transmission of HIV and other viruses such as hepatitis B and C. 16 Knowing who is enrolled and subsequently retained in a programme is essential for cost-effective forecasting and procurement of syringes, needles and other consumables; planning of logistics and human resource needs; and progressive quality and outcome improvement.…”

mentioning

confidence: 99%

Enrolment and retention of people who inject drugs in the Needle & Syringe Exchange Programme in Malaysia

Chandrasekaran

Kyaw²,

Harries

et al. 2017

public health action

View full text Add to dashboard Cite

Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors

Cited by 171 publications

References 13 publications

Benefits of concurrent syringe exchange and substance abuse treatment participation

Benefits of concurrent syringe exchange and substance abuse treatment participation

Challenges in Motivating Treatment Enrollment in Community Syringe Exchange Participants

Enrolment and retention of people who inject drugs in the Needle & Syringe Exchange Programme in Malaysia

Contact Info

Product

Resources

About